Primary Site >> Liver Cancer

Gene >> ANXA2

  • 1990
  • 1996
  • 1999
  • 2002
  • 2004
  • 2005
  • 2006
  • 2007
  • 2008
  • 2009
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma.
PMID: 2160596
Ref: Report of a complex karyotype in recurrent metastatic fibrolamellar hepatocellular carcinoma and a review of hepatocellular carcinoma cytogenetics.
PMID: 8640730
Ref: [A preliminary study of loss of heterozygosity on chromosome 1p in primary hepatocellular carcinoma].
PMID: 11869508
Ref: [A preliminary report on two distinct tumor-suppressor regions on chromosome 1p36.2-p36.3 in human hepatocellular carcinomas].
PMID: 11869529
Ref: Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma.
PMID: 12429801
Ref: Allelic imbalance at 1p36 in the pathogenesis of human hepatocellular carcinoma.
PMID: 15011861
Ref: Discrete breakpoint mapping and shortest region of overlap of chromosome arm 1q gain and 1p loss in human hepatocellular carcinoma detected by semiquantitative microsatellite analysis.
PMID: 15495198
Ref: Genome-wide semiquantitative microsatellite analysis of human hepatocellular carcinoma: discrete mapping of smallest region of overlap of recurrent chromosomal gains and losses.
PMID: 16682288
Ref: Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
PMID: 16820872
Ref: Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinoma.
PMID: 18059140
Ref: Molecular mapping of human hepatocellular carcinoma provides deeper biological insight from genomic data.
PMID: 18337085
Ref: Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
PMID: 19020748
Ref: Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method.
PMID: 19885616
Ref: Annexin A2 as a differential diagnostic marker of hepatocellular tumors.
PMID: 20971570
Ref: The association of annexin A2 and cancers.
PMID: 22855149
Ref: GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review.
PMID: 23119104
Ref: Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.
PMID: 23139605
Ref: Annexin A2 silencing inhibits invasion, migration, and tumorigenic potential of hepatoma cells.
PMID: 23840117
Ref: Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis.
PMID: 23946789
Ref: Annexin A2 promotes the migration and invasion of human hepatocellular carcinoma cells in vitro by regulating the shedding of CD147-harboring microvesicles from tumor cells.
PMID: 23950866
Ref: Inhibition of Annexin A2 gene transcription is a promising molecular target for hepatoma cell proliferation and metastasis.
PMID: 24348815
Ref: [Effects of Annexin A2 gene transcription down-regulation on human hepatoma cell biological behaviour].
PMID: 25243965
Ref: Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivo.
PMID: 25349534
Ref: Annexin A2 knockdown inhibits hepatoma cell growth and sensitizes hepatoma cells to 5-fluorouracil by regulating beta-catenin and cyclin D1 expression.
PMID: 25385370
Ref: Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.
PMID: 26109000
Ref: Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
PMID: 26547929
Ref: Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.
PMID: 26189841
Ref: Annexin A2 inhibits the migration of PASMCs stimulated with HPS rat serum by down-regulating the expression of paxillin.
PMID: 26616057
Ref: ANXA2 enhances the progression of hepatocellular carcinoma via remodeling the cell motility associated structures.
PMID: 27060670
Ref: FNDC3B promotes cell migration and tumor metastasis in hepatocellular carcinoma.
PMID: 27385217
Ref: NRBP2 Overexpression Increases the Chemosensitivity of Hepatocellular Carcinoma Cells via Akt Signaling.
PMID: 27634758
Ref: Quantitative liver proteomics identifies FGF19 targets that couple metabolism and proliferation.
PMID: 28178326
Ref: Alteration of N-glycan expression profile and glycan pattern of glycoproteins in human hepatoma cells after HCV infection.
PMID: 28229927
Ref: Downregulation of sorting nexin 10 is associated with overexpression of miR-30d during liver cancer progression in rats.
PMID: 28381192
Ref: Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients.
PMID: 28396717
Ref: Mesenchymal Stem Cells Promote Hepatocarcinogenesis via lncRNA-MUF Interaction with ANXA2 and miR-34a.
PMID: 28947421
Ref: Deep sequencing and comprehensive expression analysis identifies several molecules potentially related to human poorly differentiated hepatocellular carcinoma.
PMID: 29123978
Ref: Characterization of interactions between hepatitis C virus NS5B polymerase, annexin A2 and RNA - effects on NS5B catalysis and allosteric inhibition.
PMID: 29228983
Ref: Annexin A2 and cancer: A systematic review.
PMID: 29115416
Ref: SIRT6 Is a Target of Regulation by UBE3A That Contributes to Liver Tumorigenesis in an ANXA2-Dependent Manner.
PMID: 29217762
Ref: Hepatic Epithelioid Hemangioendothelioma.
PMID: 29372848
Ref: Identification of chromatin-accessible domains in non-alcoholic steatohepatitis-derived hepatocellular carcinoma.
PMID: 29603380
Ref: Identification of the C-Reactive Protein Interaction Network Using a Bioinformatics Approach Provides Insights into the Molecular Pathogenesis of Hepatocellular Carcinoma.
PMID: 30025407
Ref: Long non-coding RNA FOXD2-AS1 plays an oncogenic role in hepatocellular carcinoma by targeting miR206.
PMID: 30272362